Hemodynamic Risks During Emergency Tracheal Intubation

Emergency tracheal intubation in critically ill adults represents one of the most perilous procedures in acute care medicine. When clinicians secure an airway in unstable patients, profound physiological disturbances frequently occur. In particular, peri-intubation cardiovascular collapse threatens patient survival across emergency departments and intensive care units worldwide. Systemic vasodilation, abrupt loss of endogenous sympathetic tone, and positive pressure ventilation often trigger severe hypotension. Furthermore, rapid progression toward cardiac arrest can occur within minutes if teams fail to anticipate hemodynamic instability. Therefore, acute care specialists actively seek optimal induction agents that preserve vascular resistance and myocardial performance. For decades, clinicians favored ketamine for its reputed sympathomimetic benefits, while fearing etomidate for potential adrenocortical suppression. However, recent large-scale clinical trials challenge these traditional dogmas. As observational evidence and randomized data accumulate, critical care teams must reexamine their induction strategies. Consequently, understanding how anesthetic selection influences immediate hemodynamics has become a top priority for procedural safety.

Findings From the DEVICE and PREOXI Secondary Analysis

To evaluate these clinical concerns, investigators conducted a rigorous secondary analysis using combined participant data from the DEVICE and PREOXI trials. This comprehensive study examined 2357 critically ill adults who underwent rapid sequence intubation across diverse medical centers. Among the cohort, 1822 patients received etomidate, 312 received ketamine, and 223 received other induction regimens. The researchers defined cardiovascular collapse as a new or increased vasopressor infusion, a nadir systolic blood pressure below 65 mm Hg, or cardiac arrest occurring between induction and two minutes after intubation. Notably, the investigators adjusted for baseline illness severity, pre-existing shock, and hemodynamic parameters prior to induction. The primary findings revealed meaningful differences between the two primary induction agents. Specifically, patients receiving ketamine experienced higher rates of hemodynamic collapse compared to those receiving etomidate. In addition, secondary outcomes such as severe hypoxemia remained comparable across groups. Thus, this robust analysis provides compelling real-world evidence regarding the immediate circulatory consequences of choice of sedative agent during emergency airway interventions.

Cardiovascular Collapse: Ketamine Versus Etomidate Profiles

The finding that ketamine associates with increased cardiovascular collapse surprises many emergency clinicians. Historically, textbooks describe ketamine as an indirect sympathomimetic that raises heart rate and arterial pressure by inhibiting catecholamine reuptake. However, critically ill patients frequently experience severe endogenous catecholamine depletion before intubation. Under these exhausted physiological conditions, ketamine unmasks its direct, negative inotropic and myocardial depressant actions. Consequently, systemic vascular resistance drops, and cardiac output declines precipitously after drug administration. In contrast, etomidate possesses a neutral hemodynamic profile that avoids direct myocardial depression. Etomidate maintains autonomic vascular reflexes without causing profound vasodilatation. Therefore, patients induced with etomidate maintain their baseline blood pressure more reliably during the critical peri-intubation transition. Furthermore, the rapid reduction of sympathetic vascular tone during anesthesia induction disproportionately affects ketamine recipients who already balance on the brink of shock. Because of these distinct pharmacological mechanisms, clinicians should recognize that ketamine does not offer guaranteed hemodynamic protection in critically exhausted patients.

Reevaluating Sympathetic Surge and Adrenal Suppression

For decades, medical training cautioned clinicians against etomidate due to its transient inhibition of 11-beta-hydroxylase. This enzymatic blockade suppresses cortisol synthesis for 24 to 48 hours following a single induction dose. Many practitioners feared that this temporary adrenal suppression would increase vasopressor requirements and accelerate mortality, particularly in septic shock. However, large randomized controlled trials and pooled meta-analyses demonstrate no significant increase in 28-day mortality with etomidate. Meanwhile, clinicians who substituted ketamine to avoid adrenal suppression often encountered higher rates of post-induction hypotension. In addition, vasopressor escalation occurs more frequently following ketamine induction in emergency scenarios. Thus, the clinical focus must shift from theoretical biochemical suppression toward tangible peri-procedural hemodynamic stability. Although transient adrenal suppression remains a verified laboratory phenomenon, it does not translate into worse survival outcomes. On the other hand, immediate post-induction hypotension directly correlates with cardiac arrest, ischemic organ injury, and elevated intensive care mortality. Consequently, bedside providers must weigh immediate circulatory stability above downstream biochemical perturbations.

Practical Strategies for Resuscitation Before Intubation

Regardless of the chosen induction medication, clinicians must prioritize aggressive hemodynamic optimization before laryngoscopy. Resuscitation before intubation forms the cornerstone of peri-procedural patient safety in emergency medicine and intensive care. First, teams should identify patients with impending shock by checking shock index, baseline lactate, and point-of-care cardiac ultrasound. If a patient exhibits baseline hypotension or tachycardia, clinicians should initiate peripheral vasopressor infusions immediately rather than waiting for post-induction collapse. Furthermore, administering judicious fluid boluses restores venous return in hypovolemic individuals before positive pressure ventilation dampens right ventricular filling. When using ketamine in high-risk patients, reducing the induction dose from 2 mg/kg to 1 mg/kg or lower mitigates myocardial depressant actions. Similarly, combining lower sedative doses with adequate neuromuscular blockade ensures optimal intubating conditions without profound hemodynamic swings. In addition, pre-oxygenation with non-invasive positive pressure or high-flow nasal oxygen prevents concurrent severe hypoxemia. Ultimately, meticulous hemodynamic pre-treatment and thoughtful drug selection prevent disastrous peri-intubation decompensation.

Frequently Asked Questions

Why does ketamine induce hypotension in critically ill patients?

Ketamine stimulates the sympathetic nervous system by blocking catecholamine reuptake in healthy individuals. However, critically ill patients often suffer from chronic stress and severe catecholamine exhaustion. Under these compromised conditions, the drug cannot produce a sympathetic surge. Instead, ketamine exhibits its direct negative inotropic properties on cardiac myocytes. This intrinsic myocardial depression reduces stroke volume and systemic vascular resistance, precipitating acute circulatory collapse shortly after induction.

Does a single dose of etomidate increase in-hospital mortality?

A single induction dose of etomidate transiently inhibits adrenal steroidogenesis by blocking the enzyme 11-beta-hydroxylase. Although this causes measurable biochemical adrenal suppression lasting up to 48 hours, contemporary randomized trials demonstrate no increase in 28-day in-hospital mortality. Furthermore, septic patients demonstrate comparable overall survival regardless of whether clinicians choose etomidate or ketamine. Etomidate preserves immediate cardiac stability more reliably without compromising long-term mortality outcomes in emergency airway management.

How should clinicians adjust induction doses for patients in shock?

Clinicians managing critically ill patients in shock should adopt a resuscitate-before-intubate approach to maintain hemodynamic stability. If selecting ketamine, providers should reduce the standard induction dose by fifty percent, administering 0.5 to 1 mg/kg rather than 2 mg/kg. Meanwhile, clinicians should maintain full paralytic dosing to ensure prompt, successful laryngoscopy. In addition, starting prophylactic push-dose vasopressors or continuous norepinephrine infusions safeguards systemic perfusion during drug delivery.

Disclaimer: This content is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read here. Refer to the latest local and national guidelines for clinical practice.

References

Khan A et al. Ketamine Vs. Etomidates and Cardiovascular Collapse During Emergency Tracheal Intubation: A Secondary Analysis of the DEVICE and PREOXI Trials. Crit Care Explor. 2026 Nov 01. doi: 10.1097/CCE.0000000000001510. PMID: 43007299.

Casey JD, Seitz KP, Driver BE, et al. Ketamine or Etomidate for Tracheal Intubation of Critically Ill Adults. N Engl J Med. 2026;394(16):1608-1620.

Russotto V, Myatra SN, Laffey JG, et al. Intubation practices and adverse peri-intubation events in critically ill patients from 29 countries (INTUBE): an international, multicentre, prospective cohort study. Lancet Respir Med. 2021;9(6):621-632.